
Veebose 0.3mg Tablet
Marketer
Biomax Biotechnics Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Veebose 0.3mg Tablet
Glimepiride 0.3mg tablets are prescribed for managing type 2 diabetes. This medication aids in regulating postprandial hyperglycemia (high blood sugar after meals), particularly when dietary modifications and other similar medications prove insufficient. Administer this tablet immediately before meals; dosage and frequency should be determined by your physician for optimal blood glucose control. Discontinue use only under medical supervision; abrupt cessation may lead to elevated blood sugar, potentially causing serious complications such as nephropathy and visual impairment. Successful treatment necessitates a comprehensive approach including a balanced diet, regular physical activity, and weight management as recommended by your doctor. Regular blood glucose monitoring is crucial. Commonly reported side effects include abdominal distension, stomach discomfort, decreased appetite, bowel irregularity, and diarrhea. Report persistent or troublesome side effects to your physician. While unlikely to cause hypoglycemia (low blood sugar) independently, concomitant use with other antidiabetic agents (especially insulin or sulfonylureas) elevates this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective. Inform your doctor of any pre-existing kidney or liver conditions before starting this medication. Avoid use if you have bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals require medical consultation prior to commencement. Full disclosure of all current medications is essential for safe usage. Limit alcohol consumption to mitigate the risk of hypoglycemia.
Primary Ingredients of Veebose 0.3mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Veebose 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Veebose 0.3mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the Veebose 0.3mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption should occur on an empty stomach.
Common Side effects of Veebose 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Veebose 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 0.3mg Veebose Tablet should be administered on an empty stomach.
How Veebose 0.3mg Tablet works:
Glucovance 0.3mg tablets are used to manage diabetes. Their mechanism involves blocking enzymes in the gut that digest complex carbohydrates into simple sugars like glucose, thus mitigating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Veebose 0.3mg Tablets is strongly discouraged due to safety concerns.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Veebose 0.3mg tablets is typically deemed safe. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Veebose 0.3mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Veebose 0.3mg tablets.
KidneyCAUTION
For individuals with severe kidney impairment, administering Veebose 0.3mg tablets requires careful consideration. Dosage modification of Veebose 0.3mg tablets might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Veebose 0.3mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Veebose 0.3mg Tablet :
Omit any missed Veebose 0.3mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Veebose 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavior Class | Alpha-glucosidase inhibitors |
